Evidence map›Paper›PMID 24482488›Full record

ArticleSexually transmitted infections2014

High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men.

Mary K Grabowski, Ronald H Gray, David Serwadda, Godfrey Kigozi, Patti E Gravitt, Fred Nalugoda, Steven J Reynolds, Maria J Wawer, Stephen Watya, Thomas C Quinn and 1 more

Open access · greenAbstract read
In one paragraph

Article in Sexually transmitted infections, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Anal human papillomavirus and HIV: A cross-sectional study among men who have sex with men in Moscow, Russia, 2012-2013.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2015
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Mary K GrabowskiDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ronald H GrayDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Rakai Health Sciences Program, Entebbe, Uganda.
David SerwaddaRakai Health Sciences Program, Entebbe, Uganda School of Public Health, Makerere University, Kampala, Uganda.
Godfrey KigoziRakai Health Sciences Program, Entebbe, Uganda.
Patti E GravittDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Perdana University Graduate School of Medicine, Serdang, Malaysia.
Fred NalugodaRakai Health Sciences Program, Entebbe, Uganda.
Steven J ReynoldsDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Rakai Health Sciences Program, Entebbe, Uganda Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Maria J WawerDepartment of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA Rakai Health Sciences Program, Entebbe, Uganda.
Stephen WatyaDepartment of Urology, Makerere University, Kampala, Uganda.
Thomas C QuinnRakai Health Sciences Program, Entebbe, Uganda Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Aaron A R TobianRakai Health Sciences Program, Entebbe, Uganda Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Rakai Health Sciences Program · UGJohns Hopkins University · USMakerere University · UGNational Institute of Allergy and Infectious Diseases · USPerdana University · MY

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000010 · FIC · JOHNS HOPKINS UNIVERSITY · PI BEYRER, CHRISTOPHER C. · 1988 to 2012
$19.8M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Circumcision: HIV/STIs and behaviors in a RCT and post-RCT surveillance; RakaiU01AI075115 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2007 to 2011
$9.3M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
Genital Anaerobes, Inflammation and HIV Risk; RakaiR01AI087409 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H, PRICE, LANCE BRADLEY · 2010 to 2012
$2.5M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
Oncogenic HPV, Mucosal Immune Response and Risk of HIV AcquisitionK23AI093152 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2011 to 2015
$684k
FIC NIH HHS 2D43TW000010-19-AITRPFIC NIH HHS 5D43TW001508FIC NIH HHS D43 TW000010FIC NIH HHS D43 TW001508Intramural NIH HHSNIAID NIH HHS 1K23AI093152-01A1NIAID NIH HHS 3U01-AI075115-03S1NIAID NIH HHS K23 AI093152NIAID NIH HHS R01 AI087409NIAID NIH HHS R01AI087409-01A1NIAID NIH HHS U01 AI051171NIAID NIH HHS U01 AI068613NIAID NIH HHS U01-AI-068613NIAID NIH HHS U01 AI075115NIAID NIH HHS U01AI51171
6 · The paper itself

Abstract

objectivesHigh-risk human papillomavirus (HR-HPV) viral load is associated with HR-HPV transmission and HR-HPV persistence in women. It is unknown whether HR-HPV viral load is associated with persistence in HIV-negative or HIV-positive men.

methodsHR-HPV viral load and persistence were evaluated among 703 HIV-negative and 233 HIV-positive heterosexual men who participated in a male circumcision trial in Rakai, Uganda. Penile swabs were tested at baseline and 6, 12 and 24 months for HR-HPV using the Roche HPV Linear Array, which provides a semiquantitative measure of HPV shedding by hybridisation band intensity (graded: 1-4). Prevalence risk ratios (PRR) were used to estimate the association between HR-HPV viral load and persistent detection of HR-HPV.

resultsHR-HPV genotypes with high viral load (grade:3-4) at baseline were more likely to persist than HR-HPV genotypes with low viral load (grade: 1-2) among HIV-negative men (month 6: adjPRR=1.83, 95% CI 1.32 to 2.52; month 12: adjPRR=2.01, 95% CI 1.42 to 3.11), and HIV-positive men (month 6: adjPRR=1.33, 95% CI 1.06 to 1.67; month 12: adjPRR=1.73, 95% CI 1.18 to 2.54). Long-term persistence of HR-HPV was more frequent among HIV-positive men compared with HIV-negative men (month 24: adjPRR=2.27, 95% CI 1.47 to 3.51). Persistence of newly detected HR-HPV at the 6-month and 12-month visits with high viral load were also more likely to persist to 24 months than HR-HPV with low viral load among HIV-negative men (adjPRR=1.67, 95% CI 0.88 to 3.16).

conclusionsHR-HPV genotypes with high viral load are more likely to persist among HIV-negative and HIV-positive men, though persistence was more common among HIV-positive men overall. The results may explain the association between high HR-HPV viral load and HR-HPV transmission.

Indexed as

HeterosexualityViral LoadAdolescentAdultCase-Control StudiesGenotypeHIV InfectionsHuman papillomavirus 16Human papillomavirus 18Human papillomavirus 31HumansMalePapillomaviridaePapillomavirus InfectionsPenisSexual BehaviorAFRICACIRCUMCISIONHIVHPV

Identifiers

PMID24482488
PMCPMC4030299
OpenAlexW2134003725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.